IRB Members
The George Washington University (GW) IRBs are composed of more than 40 primary and alternate members representing GW faculty, staff, and students, GW Medical Faculty Associates (MFA), the GW Hospital, and non-affiliated members from the local community. With representation from a wide range of scientific disciplines and from outside the academic community, the IRB gives individualized attention to the numerous research projects being conducted by the university and its affiliates.
The IRB is comprised of two independent review committees or panels (Gold Panel 1 & Blue Panel 3). Each panel reviews research in the health and biological sciences and the social and behavioral sciences.
The Department of Health & Human Services (HHS), Office for Human Research Protections (OHRP), and the Food and Drug Administration (FDA) oversee the operations of the IRB.
IRB Chairs
- Gold Panel: David Diemert, MD
- Blue Panel: Jody Ganiban, PhD
IRB Members
| Gold Panel (Panel 1): | |
|---|---|
|
Name |
Specialty |
|
David Diemert, MD |
Tropical Medicine, Infectious Diseases |
|
Wallington, Sherrie, PhD |
Oncology, Health Disparities |
|
Claudia Ranniger, MD, PhD |
Emergency Medicine / Academics |
|
Elissa Malkin, DO, MPH |
Public Heath, Medicine |
|
Lisa Martin, MD, FACC |
Cardiology |
|
Anne Linton, MS |
Librarian |
| Blue Panel (Panel 3) | |
|---|---|
|
Name |
Specialty |
|
Jody Ganiban, PhD |
Psychology |
|
Yousif Barzani, MD |
Biomedical Laboratory Sciences |
|
Paul Ndebele, PhD |
Bioethics, Public Health |
|
Keith Boniface, MD |
Emergency Medicine |
|
Bharat Ranganath, MD |
Plastic Surgery, General Surgery |
|
Anne Linton, MS |
Librarian |
|
Mark Mishkin, MPH |
Regulatory Affairs / Public Health |
|
Richard Lush, PhD |
Clinical Trials, Oncology / Medicine |